EphMRA Meeting on 19 September 2017, Basel Switzerland
EphMRA is delighted to announce a meeting to be held in Switzerland on 19 September in Basel.
This meeting will start at 2pm CET with networking coffee and comprise of a number of interesting papers during the afternoon. The event will finish early evening with drinks and canapes and will offer great networking and learning opportunities.
The meeting will be convened by:
Sandra Cain / Florie de Blaudin, F. Hoffmann-La Roche
John Storey, Abbott Product Operations AG
Chantel Bayard, GfK
The venue is located in a very convenient location, just south of the Rhein and not far from the Rathaus. To find out exactly where it is located, here the link to the venue's website - http://www.sternen-basel.ch/contact_en.php#map-section
Gasthof zum Goldenen Sternen, St. Alban-Rheinweg 70, 4052 Basel
The meeting will be held entirely in English. The overall theme of the meeting will be announced shortly. There will be a meeting registration fee for Associate Members/suppliers and pharma non members to pay. Pharma member companies can attend for free. All Associate Member/supplier speakers need to pay the registration fee to attend and speak.
There will be a small number of papers presented as part of the meeting and we are now looking for speakers to speak on the following topics:
1. Customer Experience and Digital Usability studies - best practice
Customer Experience and Digital Usability studies are increasing in demand and prevalence within Pharma companies. Much of the research is being conducted via Digital Agencies and commissioned from internal Digital Departments. However, Digital Agencies may not be the best option for research due to their potential lack of expertise in both Pharma and Market Research. There are also many concerns around compliance, pharmacovigilance and regulatory requirements. Conversely, Specialist Pharma Research agencies are either currently not offering or only just developing this research capability. Research into Patient Journey's (online and offline) is a good example of this research area being applied to Patient Support Programmes and other digital assets. There is also the issue around wearable digital technology being used for research and the implications thereof. EphMRA is looking for papers which explore these issues and proposes best practice for online and social media research.
2. Emerging tools for gathering insight
The availability of new technologies which are being increasingly used in clinical trials, brings the opportunity to get closer to the truth in patient research as well. We are looking for papers which demonstrate how new methods and devices might be likely to change our insight gathering. Where do they fit in our insights 'toolbox' and what are the drivers and barriers to use in commercial research? Your ideas are welcomed.
3. Engaging with influencers
Identifying and understanding social influencers/their network is gaining prevalence, yet most pharmaceutical companies still do not know how best to engage these influencers to ensure for credible two-way exchange while measuring impact and managing within appropriate compliance guidelines. What is the landscape of influencer engagement in our industry today? Do influencers want to engage with us as an industry and if so, how do we sustain such relationships over time? What are true compliance hurdles vs. self-imposed restrictions? Are there non-pharmaceutical examples that we can learn from in a practical and applicable manner?
If you have any ideas which you think might fit into any of these important and relevant topics, please send your ideas using the submission form which can be found here. Your ideas are needed by Monday 1st May and please send them to Caroline Snowdon, Events Manager - email@example.com
We are looking for 3 papers in total for the afternoon, so don't delay!